Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Orchestra BioMed Hldgs Q2 EPS $(0.50) Beats $(0.51) Estimate, Sales $836.000K Beat $695.600K Estimate

Author: Benzinga Newsdesk | August 12, 2025 07:17am
Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.51) by 0.99 percent. This is a 11.11 percent decrease over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $836.000 thousand which beat the analyst consensus estimate of $695.600 thousand by 20.18 percent. This is a 7.46 percent increase over sales of $778.000 thousand the same period last year.

Posted In: OBIO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist